12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Health & Education / Health
Some 150 students join Vietnam-made Covid-19 vaccine testing
Anh Kiet - Tran Thao 17:44, 2020/12/11
There are total three testing phases - all must comply with regulations to ensure absolute safety.

About 150 students from medical and pharmaceutical universities in Hanoi have volunteered to join in a trial for Vietnam-made vaccine of Covid-1.

Launched by Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical Academy in early December, the trial has so far received many proposal from volunteers.

 Volunteers register to participate in the clinical vaccine trial program at the Vietnam Military Medical Academy. Photo: Kinhtedothi.vn

Before the testing, volunteers have to fill out the consent form and stay at the academy in at least 72 hours to confirm their qualified health condition.

Director of the Vietnam Military Medical Academy Do Quyet said that the volunteers of the phase 1 will be examined and screened before being injected as requested by the Ministry of Health. There are total three testing phases - all must comply with regulations to ensure absolute safety.

The volunteers will be discharged and instructed to follow up and take notes themselves at home. Every day the medical staff will visit or call them.

The Ministry of Health has been streamlining the administrative process to put Nanocovax vaccine into use at the shortest time. 

“Nanogen can produce two million doses of vaccine per year. During the clinical trials, we will produce the Covid-19 vaccine while upgrading the factory to optimize capacity to some 30 million doses per year," Ho Nhan, the company’s director, said.

"We plan to reach an ideal capacity of 50 million doses per year,” he added. 

"This is the first clinical trials of locally-made Covid-19 vaccine that whose research process has completed and achieved high results in the pre-clinical trial. We are making every effort to be able to produce vaccines as soon as possible," Mr. Nhan added.

Aside from Nanogen Company, three other units are developing Covid-19 vaccine in Vietnam, including Vabiotech, Polyvac and the Institute of Vaccines and Medical Biologicals (IVAC). Among them, IVAC and Vabiotech may conduct human trial in February and March 2021, respectively.

From December 10, those wishing to join Nanocovax anti-Covid-19 candidate vaccine clinical research program can register directly at the Center for Clinical Trial and Bioequivalence of the Vietnam Military Medical Academy (No. 222 Phung Hung street, Ha Dong district in Hanoi) or by phone: 0388.959.096, 0362.359.084 / 0353.212.500. Alternatively, registration can be made via email: nanocovax@nanogenpharma.com or on the website: nanogenpharma.com.

TAG: 150 students Covid-19 vaccination program human trial
Other news
06:57, 2023/57/23
Vietnam steps up vigilance against deadly Marburg
There is currently no vaccine or specific treatment for Marburg virus disease.
20:33, 2023/33/10
British couple thank Vietnamese health workers for saving their lives
"We are very grateful to the Vietnamese doctors and nurses here for saving our lives. So we decided to come back and express our sincere gratitude to our heroes".
10:03, 2023/03/03
Vietnam closely monitors passengers from H5N1-stricken areas
Vietnam keeps an eye on severe pneumonia cases in medical facilities and transport of poultry.
21:25, 2023/25/14
Hanoi to reduce third childbirth rate this year
Hanoi has been trying to keep the birth rate reasonably low and control the sex ratio at birth.
10:34, 2023/34/25
A Hanoi elite citizen with 24 years caring for people’s health
The Hanoi elite citizen is not only known as a front-line health worker against the Covid-19 pandemic but a "hero" with a compassionate heart for HIV/AIDS patients.
18:13, 2023/13/23
Vietnam shows leading role in regional health services: US CDC
Vietnam’s active role in ASEAN and its longstanding relationship in health with US CDC and neighborhood partners reinforce its position as the leading contributor to regional public health services.